Cargando…

Recent Trends in Cardiovascular Disease Mortality in Kazakhstan

INTRODUCTION: Cardiovascular diseases (CVD) are the leading cause of mortality in Kazakhstan. In the last decade, Kazakhstan has carried out a number of reforms in the healthcare sector, in particular, to reduce mortality from significant diseases, including CVD. This study aimed to provide the tren...

Descripción completa

Detalles Bibliográficos
Autores principales: Junusbekova, Gulnara, Tundybayeva, Meiramgul, Akhtaeva, Nazgul, Kosherbayeva, Lyazzat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461044/
https://www.ncbi.nlm.nih.gov/pubmed/37645218
http://dx.doi.org/10.2147/VHRM.S417693
_version_ 1785097774277066752
author Junusbekova, Gulnara
Tundybayeva, Meiramgul
Akhtaeva, Nazgul
Kosherbayeva, Lyazzat
author_facet Junusbekova, Gulnara
Tundybayeva, Meiramgul
Akhtaeva, Nazgul
Kosherbayeva, Lyazzat
author_sort Junusbekova, Gulnara
collection PubMed
description INTRODUCTION: Cardiovascular diseases (CVD) are the leading cause of mortality in Kazakhstan. In the last decade, Kazakhstan has carried out a number of reforms in the healthcare sector, in particular, to reduce mortality from significant diseases, including CVD. This study aimed to provide the trend of avoidable mortality from CVD in Kazakhstan. METHODS: We extracted data from the Bureau of National Statistics of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan on population by age; mortality rates from chronic rheumatic heart disease (I05-I09); hypertensive diseases (I10-I15); ischaemic heart disease (I20-I25); cerebrovascular diseases (I60-I69) from 2011 to 2021, by gender and 5-year age group (0, 1–4, 5–9, 74). We applied join point regression to calculate the average annual percentage change (AAPC). In addition, crude mortality and trends were calculated per 100,000 population. RESULTS: The avoidable mortality rates, including treatable and preventable mortality decreased between 2011 and 2019 and then increased in the last two years (2020 and 2021) in all four studied disease groups. The AAPC showed that total avoidable mortality rates decreased between 2011 and 2021–6.0 points (−10.6 to – 1.1) (p = 0.017), whereas in males −4.2 (−8.3 to 0.1) and females – 5.1 (−8.8 to −1.3) (p = 0.009). Avoidable mortality rates from ischemic heart disease, cerebrovascular and hypertensive disease has been reduced stronger in male compared to female. The crude mortality declined over the period given; however, among young people mortality is still high. DISCUSSION: Our findings showed that avoidable mortality from CVD decreased over the last years, which could be related to the policy on strengthening the primary care on early diagnosis and detection of CVD and its risk factors. However, primary healthcare facilities need to improve activities on health literacy (drug adherence, risk factors) of the population, including the prevention of CVD.
format Online
Article
Text
id pubmed-10461044
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104610442023-08-29 Recent Trends in Cardiovascular Disease Mortality in Kazakhstan Junusbekova, Gulnara Tundybayeva, Meiramgul Akhtaeva, Nazgul Kosherbayeva, Lyazzat Vasc Health Risk Manag Original Research INTRODUCTION: Cardiovascular diseases (CVD) are the leading cause of mortality in Kazakhstan. In the last decade, Kazakhstan has carried out a number of reforms in the healthcare sector, in particular, to reduce mortality from significant diseases, including CVD. This study aimed to provide the trend of avoidable mortality from CVD in Kazakhstan. METHODS: We extracted data from the Bureau of National Statistics of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan on population by age; mortality rates from chronic rheumatic heart disease (I05-I09); hypertensive diseases (I10-I15); ischaemic heart disease (I20-I25); cerebrovascular diseases (I60-I69) from 2011 to 2021, by gender and 5-year age group (0, 1–4, 5–9, 74). We applied join point regression to calculate the average annual percentage change (AAPC). In addition, crude mortality and trends were calculated per 100,000 population. RESULTS: The avoidable mortality rates, including treatable and preventable mortality decreased between 2011 and 2019 and then increased in the last two years (2020 and 2021) in all four studied disease groups. The AAPC showed that total avoidable mortality rates decreased between 2011 and 2021–6.0 points (−10.6 to – 1.1) (p = 0.017), whereas in males −4.2 (−8.3 to 0.1) and females – 5.1 (−8.8 to −1.3) (p = 0.009). Avoidable mortality rates from ischemic heart disease, cerebrovascular and hypertensive disease has been reduced stronger in male compared to female. The crude mortality declined over the period given; however, among young people mortality is still high. DISCUSSION: Our findings showed that avoidable mortality from CVD decreased over the last years, which could be related to the policy on strengthening the primary care on early diagnosis and detection of CVD and its risk factors. However, primary healthcare facilities need to improve activities on health literacy (drug adherence, risk factors) of the population, including the prevention of CVD. Dove 2023-08-23 /pmc/articles/PMC10461044/ /pubmed/37645218 http://dx.doi.org/10.2147/VHRM.S417693 Text en © 2023 Junusbekova et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Junusbekova, Gulnara
Tundybayeva, Meiramgul
Akhtaeva, Nazgul
Kosherbayeva, Lyazzat
Recent Trends in Cardiovascular Disease Mortality in Kazakhstan
title Recent Trends in Cardiovascular Disease Mortality in Kazakhstan
title_full Recent Trends in Cardiovascular Disease Mortality in Kazakhstan
title_fullStr Recent Trends in Cardiovascular Disease Mortality in Kazakhstan
title_full_unstemmed Recent Trends in Cardiovascular Disease Mortality in Kazakhstan
title_short Recent Trends in Cardiovascular Disease Mortality in Kazakhstan
title_sort recent trends in cardiovascular disease mortality in kazakhstan
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461044/
https://www.ncbi.nlm.nih.gov/pubmed/37645218
http://dx.doi.org/10.2147/VHRM.S417693
work_keys_str_mv AT junusbekovagulnara recenttrendsincardiovasculardiseasemortalityinkazakhstan
AT tundybayevameiramgul recenttrendsincardiovasculardiseasemortalityinkazakhstan
AT akhtaevanazgul recenttrendsincardiovasculardiseasemortalityinkazakhstan
AT kosherbayevalyazzat recenttrendsincardiovasculardiseasemortalityinkazakhstan